Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia

被引:4
作者
Pan, Elizabeth [1 ]
Hsieh, Eric [1 ]
Piatek, Caroline [2 ]
机构
[1] USC, Keck Sch Med, Dept Med, 1450 San Pablo St Suite 3000, Los Angeles, CA 90033 USA
[2] USC, Keck Sch Med, Dept Med, Div Hematol, Los Angeles, CA USA
来源
CASE REPORTS IN ONCOLOGY | 2018年 / 11卷 / 03期
关键词
Adenocarcinoma; Oxaliplatin; Thrombocytopenia;
D O I
10.1159/000495032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including malignancy itself, acute disease processes, or cancer therapy. Systemic cancer therapy is the most common cause of thrombocytopenia in cancer patients observed nearly twothirds of patients with solid tumors. Thrombocytopenia with traditional chemotherapy agents is most frequently the result of megakaryocyte cytotoxicity. Oxaliplatin is a platinum derivative commonly used in gastrointestinal malignancies and is associated with drug-induced immune thrombocytopenia. (c) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:880 / 882
页数:3
相关论文
共 10 条
[1]   Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature [J].
Bautista, Marnelli A. ;
Stevens, W. Tait ;
Chen, Chien-Shing ;
Curtis, Brian R. ;
Aster, Richard H. ;
Hsueh, Chung-Tsen .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
[2]   Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin [J].
Curtis, BR ;
Kaliszewski, J ;
Marques, MB ;
Saif, MW ;
Nabelle, L ;
Blank, J ;
McFarland, JG ;
Aster, RH .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (03) :193-198
[3]  
Dold Frederick G, 2003, Ann Intern Med, V139, pE156
[4]   Oxaliplatin-related thrombocytopenia [J].
Jardim, D. L. ;
Rodrigues, C. A. ;
Novis, Y. A. S. ;
Rocha, V. G. ;
Hoff, P. M. .
ANNALS OF ONCOLOGY, 2012, 23 (08) :1937-1942
[5]   Thrombocytopenia in cancer patients [J].
Liebman, Howard A. .
THROMBOSIS RESEARCH, 2014, 133 :S63-S69
[6]   Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature [J].
Ohta, Shoichiro ;
Cho, Yukiko ;
Oshima, Shinji ;
Hosoya, Osamu ;
Juni, Kazuhiko ;
Kojima, Hiroshi .
ONCOLOGY LETTERS, 2012, 3 (06) :1297-1300
[7]  
Piatek CI, PLATELETS THROMBOTIC, DOI [10.1007/978-3-319-47462-5_56, DOI 10.1007/978-3-319-47462-5_56]
[8]   A case of oxaliplatin-induced immune-mediated thrombocytopenia [J].
Suh, Seong Eun ;
Jang, Moon Ju ;
Chong, So Young ;
Aster, Richard H. ;
Curtis, Brian R. ;
Oh, Doyeun .
BLOOD RESEARCH, 2014, 49 (01) :61-64
[9]   Oxaliplatin-induced immune pancytopenia [J].
Taleghani, BM ;
Fontana, S ;
Meyer, O ;
Ahrens, N ;
Novak, U ;
Borner, MM ;
Salama, A .
TRANSFUSION, 2005, 45 (05) :704-708
[10]   Anemia and Thrombocytopenia in Patients Undergoing Chemotherapy for Solid Tumors: A Descriptive Study of a Large Outpatient Oncology Practice Database, 2000-2007 [J].
Wu, Ying ;
Aravind, Suresh ;
Ranganathan, Gayatri ;
Martin, Amber ;
Nalysnyk, Luba .
CLINICAL THERAPEUTICS, 2009, 31 :2416-2432